4.2 Article

Alcoholic steatohepatitis

期刊

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.bpg.2010.07.003

关键词

Alcoholic hepatitis; Acetaldehyde; Corticosteroids; Endotoxins; Enteral nutrition; Liver failure; Liver transplantation; Pentoxifylline; Tumour necrosis factor

资金

  1. Dietmar Hopp and Manfred Lautenschlager Foundation
  2. European Research Advisory Board (ERAB)

向作者/读者索取更多资源

Severe alcoholic steatohepatitis has a poor prognosis and is characterized by jaundice and signs of liver failure Its incidence is unknown but prevalence is around 20% in cohorts of alcoholics undergoing liver biopsy Diagnosis is established with elevated liver transaminases neutrophil counts serum bilirubin and impaired coagulation and a history of excessive alcohol consumption and exclusion of other etiologies Histology is helpful but not mandatory Prognostic scores include the Maddrey s discriminant function the model of end-stage liver disease and the Glasgow Alcoholic Hepatitis Score Pathophysiology involves hepatic fat storage increased hepatic uptake of gut-derived endotoxins triggering Kupffer cell activation and release of proinflammatory triggers induction of cytochrome P4502E1 producing toxic acetaldehyde and reactive oxygen species and ethanol-mediated hyperhomocysteinemia causing endoplasmic reticulum stress Treatment includes abstinence enteral nutrition corticosteroids and possibly pentoxifylline A debate is ongoing whether certain patients with severe alcoholic steatohepatitis could be eligible for liver transplantation (C) 2010 Elsevier Ltd All rights reserved

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据